ACACA and non-small cell lung carcinoma: To determine whether ACC1 contributes to the formation of gefitinib resistance in NSCLC cells, we attenuated the activity of ACC1 in HCC827/GR cells using firsocostat (an ACC1 inhibitor) and ACC1 knockdown (Fig. 7C), respectively.